Dr Oz Ridiculed for Urging Parents to Feed Their Kids 'Real Food': 'When Michelle Obama Said This It Was Communism'
Dr. Mehmet Oz is being derided by social media users online after encouraging parents to feed their children "real food" in order to boost health and immunity during a televised interview.
Oz, who is the new administrator of the Centers for Medicare & Medicaid Services, appeared on Fox News while visiting Philadelphia in an effort to promote the administration's goal of making America healthy again. Speaking to host Lawrence B. Jones, Oz told parents to feed their children real food that "comes out of the ground".
"Give them real food. You heard Secretary Kennedy talk about how 70% of the food is ultra-processed. Just give them food that comes out of the ground looking the way it looks when you eat it. Real food that you can recognize ... It's also your patriotic duty because less than a quarter of kids are eligible for the military because they've got underlying health issues," said Oz.
Oz said the same thing earlier in an interview with CBS News Philadelphia health reporter Stephanie Stahl before attending an event in West Philadelphia on Monday.
"If you eat real food, food that comes out of the ground looking the way it looks when you eat it, that is the recipe for a healthy diet," Oz said.
Social media users took to online platforms to mock Dr. Oz's advice.
"When Michelle Obama said this it was communism..." wrote one user.
"It was called the Liberal Nanny State when the Obamas tried to improve the quality of school lunches nationwide," wrote another.
"There is no one who doesn't agree...but it isn't possible with currently funded school budgets, budgets that Trump is decreasing...costs which Trump is increasing (tariffs and immigrants)...so good luck with that," said a third.
"So, Trump and MAGA are finally preaching about healthy eating and exercise for kids? Wow, what a groundbreaking revelation from the party that spent years mocking Michelle Obama for the same thing," said a fourth.
Health and Human Services Secretary Robert F. Kennedy Jr. has repeatedly advocated for cleaner food being fed to children, claiming that food provided to kids in schools is filled with toxic dyes and additives.
"We need to stop poisoning our kids and make sure that Americans are once again the healthiest kids on the planet," Kennedy said at an event with U.S. Department of Agriculture Secretary Brooke Rollins.
Originally published on Latin Times
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Int'l Business Times
4 days ago
- Int'l Business Times
GOP Senator Ridiculed for Insisting Americans 'Transitioning From Medicaid' Will Get Insurance From Employers: 'Do Employers Know?'
A Republican Senator is being ridiculed online for stating that the millions of people that will be removed from Medicaid if President Donald Trump's "one big, beautiful bill" passes will then transition to employer-provided healthcare. Oklahoma Senator James Lankford appeared on CNBC's 'Squawk Box' in conversation with host Rebecca Quick on Thursday, where he discussed the potential impacts of the Trump-back GOP spending bill. "People are screaming and saying, 'It's kicking people off Medicaid.' It's not kicking people off Medicaid. It's transitioning from Medicaid to employer-provided healthcare. So yes, we've got 10 million people that are not gonna be on Medicaid, but they then are gonna be on employer-provided healthcare," said Lankford. Social media users reacted incredulously, mocking Lankford for assuming that millions of people would immediately have access to employer provided healthcare options. "Do the employers who don't provide health insurance know??" said one user. "Except when your minimum wage job has no healthcare," said another. "So it's kicking people off medicaid," wrote a third. "That's IF the employer provides healthcare that is affordable! These are working poor who live paycheck to paycheck and have little left to afford healthcare!" concurred a fourth. Lankford, who is a member of the Finance Committee, met with Trump to discuss the tax and spending bill on Wednesday. He continued to outline what exactly legislators discussed with Trump in the meeting. "About a two hour conversation about what's happening on taxes, what are agreements going to be, what direction we're going to try and take. It was broad in many areas. The House has already passed their piece, the Senate has got to pass our piece then that's going to line up with the House and the President has got to sign. It's very important that we align all three right now, so it was a coordination meeting yesterday quite frankly," said Lankford. Originally published on Latin Times
Int'l Business Times
6 days ago
- Int'l Business Times
Trump's Cognitive 'Decline' Suggests He 'Might Not Make It Through Four Years,' Republican Strategist Says
A Republican strategist warned that President Donald Trump's accelerating "cognitive decline" could prevent him from completing his second term. In an interview with Times Radio, Lincoln Project co-founder Rick Wilson claimed Trump is no longer the same political force seen during his previous campaigns, saying his speech, memory, and coherence have visibly deteriorated. "He is incoherent," Wilson said. "His inability to articulate any thought or position without constant asides, constant lapses... this is not the Trump of 2015, nor is he the Trump of 2020. He's not even the Trump of 2024." gun pixabay Wilson pointed to verbal lapses and behavioral patterns that, he says, mirror early signs of dementia. While acknowledging he's not a medical professional, he alleged many neurological experts see troubling similarities. Despite these concerns, the White House physician, Captain Sean Barbabella, issued a clean bill of health in April, stating Trump "exhibits excellent cognitive and physical health." Wilson, however, argued that Trump's age and long-standing health habits cast doubts over his ability to withstand the grueling demands of the presidency through 2029. "He's a guy who's subsisted off of McDonald's and Kentucky Fried Chicken and well done steaks for a very long time," he said. "He is not a healthy guy." "Whether he makes it through four years is an open question," Wilson said. "Given the pace of the decline that we've seen...I think he'll be pretty much checked out by the middle of this second term." The president has consistently dismissed concerns about his health, frequently boasting about passing cognitive tests. "I don't know that he's going to ever be told by anyone, 'Sir you're not healthy, you can't do this anymore,'" Wilson said, predicting internal strife on the horizon. "But I think by the end of this, you're going to be in a civil war with the MAGAs to choose a successor." The speculation follows not only scrutiny of Trump's cognitive aptitude, but bombshell reports of former President Joe Biden's cognitive decline toward the end of his term, and of efforts taken to conceal his diminishing mental acuity from the public. Originally published on Latin Times
Int'l Business Times
6 days ago
- Int'l Business Times
At No Cost to Federal Government a Lifeline for America's Communities
As the U.S. healthcare system wrestles with rising costs and deepening disparities, one federal program quietly continues to serve as a financial and clinical lifeline for millions of Americans: the 340B Drug Pricing Program. Since its inception in 1992, 340B has enabled safety net hospitals, community health centers, and other providers to purchase outpatient medications at reduced prices. These savings aren't about boosting bottom lines—they're about keeping doors open, expanding access to care, and delivering essential services for all. At its heart, 340B is about getting medicine—and the healthcare services needed to ensure their safe and effective use—to people who otherwise might go without it. It empowers hospitals that serve high numbers of uninsured and modest-income patients, as well as Federally Qualified Health Centers (FQHCs) and Ryan White clinics that reach the working poor. The savings realized under 340B are not pocketed. These providers invest funds directly into programs that offer mental health services, treat substance use disorders, fund mobile clinics, and support chronic disease management. In many cases, access to the 340B program is the determining factor in whether a provider can afford to keep its pharmacy open to serve those who would otherwise go without treatment. The 340B program is a small program with big benefits. The discounts provided account for only 3% of drug companies' global revenues . At the same time, drug price increases continue to rise faster than inflation. In the United States, where drug companies already benefit from federally supported insurance programs and drug prices that are over three times higher than the rest of OECD countries, the 340B program is a reasonable accommodation to meet their obligations to be good corporate citizens. While the impact of the 340B program on drug companies is minimal, the impact on health is significant. Take community health centers, for example. These organizations are often the only providers in rural towns or urban neighborhoods. With the help of 340B, they can offer sliding scale fees, reach out to patients who are unhoused or living in poverty, and provide preventive care and health screenings that are crucial in addressing rising healthcare costs. For diseases like diabetes, 340B drug pricing ensures access to both medications as well as the patient education and healthcare provider services needed to effectively manage a complex chronic condition. In short, they make health more than a buzzword—they make it real. Hospitals also depend on 340B to sustain emergency rooms, neonatal intensive care units, and oncology programs. Small rural hospitals in particular often rely on these savings to remain operational. When one of these facilities shuts down, the consequences are immediate and severe: longer travel times for urgent care, delayed treatments, and a deeper strain on already stressed healthcare systems. Despite its impact, 340B has come under fire from some in the pharmaceutical industry and others who argue the program is being misused or lacks sufficient oversight. While oversight improvements are a worthy discussion, such criticisms ignore the real-world pressures providers face: skyrocketing drug prices, declining reimbursements, and the increasing demand for services as the population ages and grows more medically complex. Along with reasonable reforms that support program integrity, it's time to make common sense changes to reduce the regulatory burden on providers and let them focus on their main job—delivering high-quality health care to all. In the current budgetary environment, maintaining the 340B program is more important than ever. The program doesn't add to the federal budget. Instead, it gives healthcare providers the means to stretch existing resources further—just as Congress intended. Reducing or eliminating the 340B program to increase the profit of global pharmaceutical companies would shift costs to patients while simultaneously putting additional strains on state and federal budgets at the worst possible time. Undermining the 340B program would not just threaten individual institutions—it would unravel an already fragile health infrastructure. The people most affected would be those with the fewest options: modest and low-wage workers, rural residents, and those without insurance. The 340B program is a critical bridge between affordability and access, between policy and people. While reforms of the program may be useful, it is imperative they be guided with an overarching goal of improving how the program works for patients, not of providing a windfall for pharmaceutical manufacturers, who have experienced record profits since the program's inception. Weakening the 340B program would be short-sighted and harmful. Strengthening it is a fiscal imperative—for hospitals, clinics, and all communities. Author: Jane L. Delgado, Ph.D., M.S., is a highly esteemed and in-demand analyst and thought leader. She is the President and CEO of an NGO, Healthy Americas Foundation (HAF). She sits on the boards of the U.S. Soccer Foundation (Chair, Audit), McLean Hospital (Belmont, MA), the National Biodefense Science Advisory Board, the Lovelace Biomedical Research Institute (Investment Committee), and Argonne National Labs (Chair, Compensation).
